{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": ".beta..sub.3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia", "item": "https://www.patentleaderboard.com/patent/5627200"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › .beta..sub.3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia

.beta..sub.3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia

US Patent 5627200 · Granted May 6, 1997

Estimated economic value: $113,812,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

WRN inhibitors2025
WRN inhibitors2025
Chemical compounds2024
Chemical compounds2023
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors2023
Chemical compounds2021
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors2020
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors2019
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors2018
2-thiopyrimidinones2018
2-thiopyrimidinones2016
N1/N2-lactam acetyl-CoA carboxylase inhibitors2015